Cargando…
An Anticancer Rhenium Tricarbonyl Targets Fe−S Cluster Biogenesis in Ovarian Cancer Cells
Target identification remains a critical challenge in inorganic drug discovery to deconvolute potential polypharmacology. Herein, we describe an improved approach to prioritize candidate protein targets based on a combination of dose‐dependent chemoproteomics and treatment effects in living cancer c...
Autores principales: | Neuditschko, Benjamin, King, A. Paden, Huang, Zhouyang, Janker, Lukas, Bileck, Andrea, Borutzki, Yasmin, Marker, Sierra C., Gerner, Christopher, Wilson, Justin J., Meier‐Menches, Samuel M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827826/ https://www.ncbi.nlm.nih.gov/pubmed/36004624 http://dx.doi.org/10.1002/anie.202209136 |
Ejemplares similares
-
Rhenium Tricarbonyl Complexes of Azodicarboxylate Ligands
por: Jordan, Rose, et al.
Publicado: (2022) -
A Proteomic Platform Enables to Test for AML Normalization In Vitro
por: Meier-Menches, Samuel M., et al.
Publicado: (2022) -
Target-specific mononuclear and binuclear rhenium(i) tricarbonyl complexes as upcoming anticancer drugs
por: Sharma S., Ajay, et al.
Publicado: (2022) -
Finger sweat analysis enables short interval metabolic biomonitoring in humans
por: Brunmair, Julia, et al.
Publicado: (2021) -
Eicosanoid Content in Fetal Calf Serum Accounts for Reproducibility Challenges in Cell Culture
por: Niederstaetter, Laura, et al.
Publicado: (2021)